• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
sMICA and its emerging role as a prognostic and diagnostic indicator in systemic malignancies besides hepatocellular carcinoma.可溶性MICA及其在除肝细胞癌外的系统性恶性肿瘤中作为预后和诊断指标的新作用。
Chin J Cancer. 2013 Apr;32(4):224. doi: 10.5732/cjc.012.10234. Epub 2013 Mar 15.
2
Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma.晚期肝细胞癌患者血清中可溶性MICA水平的预后价值
Chin J Cancer. 2013 Mar;32(3):141-8. doi: 10.5732/cjc.012.10025. Epub 2012 Jun 14.
3
Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.可溶性MHC I类相关链A对晚期人类肝细胞癌中自然杀伤细胞和树突状细胞功能的损害。
J Hepatol. 2005 Dec;43(6):1013-20. doi: 10.1016/j.jhep.2005.05.026. Epub 2005 Jun 29.
4
Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma.慢性肝病和肝细胞癌中自然杀伤细胞的免疫特征和治疗方法。
J Gastroenterol Hepatol. 2024 Sep;39(9):1717-1727. doi: 10.1111/jgh.16584. Epub 2024 May 27.
5
[The significance of peripheral blood natural killer cell surface CD NKG2D and serum sMICA in patients with extranodal NK/T cell lymphoma, nasal type].[外周血自然杀伤细胞表面CD NKG2D及血清sMICA在鼻型结外NK/T细胞淋巴瘤患者中的意义]
Zhonghua Nei Ke Za Zhi. 2016 Nov 1;55(11):872-874. doi: 10.3760/cma.j.issn.0578-1426.2016.11.012.
6
Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.循环可溶性 MHC Ⅰ类相关链 A（sMICA）和 sMICB 浓度增加及质膜 MICA 表达的调节：系统性红斑狼疮中潜在的机制及与自然杀伤细胞活性的相关性。
Front Immunol. 2021 May 3;12:633658. doi: 10.3389/fimmu.2021.633658. eCollection 2021.
7
Anti-hepatocarcinoma activity of TT-1, an analog of melittin, combined with interferon-α via promoting the interaction of NKG2D and MICA.蜂毒肽类似物TT-1与α干扰素联合通过促进NKG2D与MICA的相互作用发挥抗肝癌活性。
J Zhejiang Univ Sci B. 2017 Jun;18(6):522-531. doi: 10.1631/jzus.B1600369.
8
Scorpion venom activates natural killer cells in hepatocellular carcinoma via the NKG2D-MICA pathway.蝎毒通过NKG2D-MICA途径激活肝细胞癌中的自然杀伤细胞。
Int Immunopharmacol. 2016 Jun;35:307-314. doi: 10.1016/j.intimp.2016.03.045. Epub 2016 Apr 16.
9
Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.成纤维细胞生长因子-2 增强肝癌细胞的 NK 敏感性。
Int J Cancer. 2012 Jan 15;130(2):356-64. doi: 10.1002/ijc.26003. Epub 2011 Apr 25.
10
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.组蛋白去乙酰化酶抑制剂丙戊酸钠通过特异性诱导NKG2D配体介导自然杀伤细胞对肝癌细胞的杀伤作用。
Cancer Res. 2005 Jul 15;65(14):6321-9. doi: 10.1158/0008-5472.CAN-04-4252.

本文引用的文献

1
Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma.晚期肝细胞癌患者血清中可溶性MICA水平的预后价值
Chin J Cancer. 2013 Mar;32(3):141-8. doi: 10.5732/cjc.012.10025. Epub 2012 Jun 14.
2
Clinical significance of serum levels of immune-associated molecules, uric acid and soluble MHC class I chain-related molecules A and B, as diagnostic tumor markers for pancreatic ductal adenocarcinoma.血清免疫相关分子、尿酸和可溶性 MHC Ⅰ类链相关分子 A 和 B 水平对胰腺导管腺癌诊断肿瘤标志物的临床意义。
Cancer Sci. 2011 Sep;102(9):1673-9. doi: 10.1111/j.1349-7006.2011.01989.x. Epub 2011 Jul 3.
3
[Association of MICA gene polymorphism and serum soluble MICA level with colorectal cancer].[MICA基因多态性及血清可溶性MICA水平与结直肠癌的相关性]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Jun;27(3):335-9. doi: 10.3760/cma.j.issn.1003-9406.2010.0.022.
4
Relationship between soluble MICA and the MICA A5.1 homozygous genotype in patients with oral squamous cell carcinoma.口腔鳞状细胞癌患者中可溶性MICA与MICA A5.1纯合基因型之间的关系。
Clin Immunol. 2009 Mar;130(3):331-7. doi: 10.1016/j.clim.2008.09.004. Epub 2008 Oct 23.
5
[The roles of soluble MICA in immune escape of breast tumor].[可溶性MICA在乳腺肿瘤免疫逃逸中的作用]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 Sep;24(9):904-7.
6
Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients.日本患者中可溶性MICA水平与IV期口腔鳞状细胞癌疾病分期之间的关联。
Hum Immunol. 2008 Feb;69(2):88-93. doi: 10.1016/j.humimm.2008.01.010. Epub 2008 Feb 22.
7
[Expression of membrane/soluble MHC class I chain-related molecule A and NKG2D receptor in osteosarcoma and its clinical significance].[膜/可溶性MHC I类链相关分子A和NKG2D受体在骨肉瘤中的表达及其临床意义]
Zhonghua Bing Li Xue Za Zhi. 2007 Sep;36(9):596-9.
8
Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.可溶性MICA作为多发性骨髓瘤患者总生存期和无进展生存期的独立预后因素。
Clin Immunol. 2007 Apr;123(1):114-20. doi: 10.1016/j.clim.2006.11.007. Epub 2007 Jan 10.

sMICA and its emerging role as a prognostic and diagnostic indicator in systemic malignancies besides hepatocellular carcinoma.

作者信息

Kapoor Shailendra

出版信息

Chin J Cancer. 2013 Apr;32(4):224. doi: 10.5732/cjc.012.10234. Epub 2013 Mar 15.

DOI:10.5732/cjc.012.10234
PMID:23489588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3845571/
Abstract
摘要